GHO Capital-owned Caprion Biosciences acquires Serametrix
Caprion Biosciences Inc has acquired Serametrix Corp, a Carlsbad, California-based provider of immune monitoring services. No financial terms were disclosed. Caprion, a Montréal-based provider of immunology and proteomics services to the biopharmaceutical industry, said it will leverage Serametrix's expertise in the analysis of myeloid-derived suppressor cells and its global operations. The add-on deal is Caprion’s third since the company's acquisition in 2016 by U.K. healthcare private equity firm GHO Capital Partners. The seller was Chicago Growth Partners. Founded in 2000, Caprion is led by President and CEO Martin Leblanc.
30 April 2019•3 mins read
